Related references
Note: Only part of the references are listed.Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma
Arndt Vogel et al.
CANCER TREATMENT REVIEWS (2020)
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy
Po-Chun Chen et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Tatsuo Kanda et al.
HEPATOLOGY INTERNATIONAL (2019)
Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease
Wei-Chen Lin et al.
MEDICINE (2019)
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals
Edoardo G. Giannini et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Thomas F. Baumert et al.
GASTROENTEROLOGY (2019)
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
Chen-Hua Liu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
Omar El-Sherif et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
Maria Guarino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
Alberto Ferrarese et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib
Tomokazu Kawaoka et al.
ONCOLOGY (2017)
Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
Luciana Kikuchi et al.
CLINICS (2017)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Management of liver cirrhosis between primary care and specialists
Ignazio Grattagliano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Hepatitis c virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study
Savino Bruno et al.
HEPATOLOGY (2007)
Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways
Kazuhiko Koike
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
